These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Use of interferon-beta in the treatment of multiple sclerosis. Derwenskus J; Lublin FD Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838 [No Abstract] [Full Text] [Related]
6. [Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies]. Pette M; Hartung HP; Toyka KV Nervenarzt; 1994 Apr; 65(4):271-4. PubMed ID: 8015636 [No Abstract] [Full Text] [Related]
7. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis. Karenfort M; Kieseier BC; Tibussek D; Assmann B; Schaper J; Mayatepek E Dev Med Child Neurol; 2009 Feb; 51(2):159-61. PubMed ID: 19191848 [No Abstract] [Full Text] [Related]
8. Autoimmune diseases. The B cell slayer. Matthews R Science; 2007 Nov; 318(5854):1232-3. PubMed ID: 18033858 [No Abstract] [Full Text] [Related]
9. [Corticosteroids in the treatment of multiple sclerosis and optic neuritis]. Elovaara I; Pirttilä T Duodecim; 2000; 116(15):1547-54. PubMed ID: 12001474 [No Abstract] [Full Text] [Related]
10. Treatment options for multiple sclerosis: current and emerging therapies. Gawronski KM; Rainka MM; Patel MJ; Gengo FM Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of multiple sclerosis--now and in future. The Danish Multiple Sclerosis Society and the Danish Multiple Sclerosis Group]. Sellebjerg FT; Sørensen PS; Ugeskr Laeger; 2007 Mar; 169(12):1121. PubMed ID: 17394832 [No Abstract] [Full Text] [Related]